| 1. |
Krauss GL, Klein P, Brandt C, et al. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. The Lancet. Neurology, 2020, 19(1): 38-48.
|
| 2. |
Klein P, Krauss GL, Steinhoff BJ, et al. Failure to use new breakthrough treatments for epilepsy. Epilepsia, 2023, 64(6): 1458-1465.
|
| 3. |
Sperling MR, Abou‐Khalil B, Aboumatar S, et al. Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study. Epilepsia, 2021, 62(12): 3005-3015.
|
| 4. |
Sperling MR, Wheless JW, Hogan RE, et al. Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out-of-hospital seizure clusters: Results from a phase 3, open-label, repeat-dose safety study. Epilepsia, 2022, 63(4): 836-843.
|
| 5. |
Misra SN, Sperling MR, Rao VR, et al. Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters. Epilepsia, 2022, 63(10): 2684-2693.
|
| 6. |
Kuersten M, Tacke M, Gerstl L, et al. Antiepileptic therapy approaches in KCNQ2 related epilepsy: a systematic review. European Journal of Medical Genetics, 2020, 63(1): 103628.
|
| 7. |
Knight D, Mahida S, Kelly M, et al. Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy. Epilepsia, 2023, 64(7): e143-e147.
|
| 8. |
Kellinghaus C, Rossetti AO, Trinka E, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Annals of Neurology, 2019, 85(3): 421-432.
|
| 9. |
Tipton A E, Cruz Del Angel Y, Hixson K, et al. Selective neuronal knockout of STAT3 function inhibits epilepsy progression, improves cognition, and restores dysregulated gene networks in a temporal lobe epilepsy model. Annals of Neurology, 2023, 94(1): 106-122.
|
| 10. |
Shuman T, Aharoni D, Cai DJ, et al. Breakdown of spatial coding and interneuron synchronization in epileptic mice. Nature Neuroscience, 2020, 23(2): 229-238.
|
| 11. |
Borzello M, Ramirez S, Treves A, et al. Assessments of dentate gyrus function: discoveries and debates. Nature Reviews. Neuroscience, 2023, 24(8): 502-517.
|
| 12. |
Lenck-Santini P-P, Holmes G L. Altered phase precession and compression of temporal sequences by place cells in epileptic rats. The Journal of Neuroscience, 2008, 28(19): 5053-5062.
|
| 13. |
Kahn J B, Port R G, Yue C, et al. Circuit-based interventions in the dentate gyrus rescue epilepsy-associated cognitive dysfunction. Brain, 2019, 142(9): 2705-2721.
|
| 14. |
Wick Z C, Philipsberg P A, Lamsifer S I, et al. Manipulating single-unit theta phase-locking with PhaSER: An open-source tool for real-time phase estimation and manipulation. bioRxiv, 2023: 2023.02. 21.529420.
|
| 15. |
Yin F, Ni D, Xu C, et al. Auras in intractable frontal lobe epilepsy: clinical characteristics, values, and limitations. Epilepsy & Behavior:E& B, 2021, 115: 107724.
|
| 16. |
Pelliccia V, Avanzini P, Rizzi M, et al. Association between semiology and anatomo-functional localization in patients with cingulate epilepsy: a cohort study. Neurology, 2022, 98(22): e2211-e2223.
|
| 17. |
Pérez-García F, Alim-Marvasti A, Romagnoli G, et al. Software tool for visualization of a probabilistic map of the epileptogenic zone from seizure semiologies. Frontiers in Neuroinformatics, 2022, 16: 990859.
|
| 18. |
Bingaman N, Ferguson L, Thompson N, et al. The relationship between mood and anxiety and cognitive phenotypes in adults with pharmacoresistant temporal lobe epilepsy. Epilepsia, 2023, 64(12): 3331-3341.
|
| 19. |
Ziaei M, Arnold C, Thompson K, et al. Social cognition in temporal and frontal lobe epilepsy: systematic review, meta-analysis, and clinical recommendations. Journal of the International Neuropsychological Society, 2023, 29(2): 205-229.
|
| 20. |
Caller TA, Ferguson RJ, Roth RM, et al. A cognitive behavioral intervention (HOBSCOTCH) improves quality of life and attention in epilepsy. Epilepsy & Behavior, 2016, 57(Pt A): 111–117.
|
| 21. |
Akula SK, Chen AY, Neil JE, et al. Exome sequencing and the identification of new genes and shared mechanisms in polymicrogyria. JAMA Neurology, 2023, 80(9): 980-988.
|
| 22. |
D’Gama AM, Mulhern S, Sheidley B R, et al. Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study. The Lancet Neurology, 2023, 22(9): 812-825.
|
| 23. |
Koh HY, Smith L, Wiltrout KN, et al. Utility of exome sequencing for diagnosis in unexplained pediatric-onset epilepsy. JAMA Network Open, 2023, 6(7): e2324380.
|
| 24. |
Sheidley BR, Malinowski J, Bergner AL, et al. Genetic testing for the epilepsies: a systematic review. Epilepsia, 2022, 63(2): 375-387.
|
| 25. |
Smith L, Malinowski J, Ceulemans S, et al. Genetic testing and counseling for the unexplained epilepsies: an evidence-based practice guideline of the National Society of Genetic Counselors. Journal of Genetic Counseling, 2023, 32(2): 266-280.
|
| 26. |
Wagstyl K, Adler S, Pimpel B, et al. Planning stereoelectroencephalography using automated lesion detection: Retrospective feasibility study. Epilepsia, 2020, 61(7): 1406-1416.
|
| 27. |
Spitzer H, Ripart M, Whitaker K, et al. Interpretable surface-based detection of focal cortical dysplasias: a Multi-centre Epilepsy Lesion Detection study. Brain, 2022, 145(11): 3859-3871.
|
| 28. |
Gill RS, Lee HM, Caldairou B, et al. Multicenter validation of a deep learning detection algorithm for focal cortical dysplasia. Neurology, 2021, 97(16): e1571-e1582.
|
| 29. |
Jobst BC, Cascino GD. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA, 2015, 313(3): 285-293.
|
1/5
WeChat